Metraipolis › archive › dc_af3fcbd71b7e

Harnessing cellular immunotherapy for cholangiocarcinoma: an integrated roadmap for overcoming resistance — Europe PMC PMID:42183240

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42183240
DOI
10.3389/fimmu.2026.1757504
License (as archived)
solo-consultazione
Archived
2026-11-02T15:23:17.493Z
SHA-256 of the archived text
e17ec88e692fe12d8ee613043748a3e3792d782604ab5a8c4227b24fdbe3a7fc
Stable URL of this page
https://metraipolis.com/documento/dc_af3fcbd71b7e

How to cite

Harnessing cellular immunotherapy for cholangiocarcinoma: an integrated roadmap for overcoming resistance — Europe PMC PMID:42183240 — Europe PMC (en), https://europepmc.org/article/MED/42183240 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af3fcbd71b7e (Metraipolis archive dc_af3fcbd71b7e, sha256 e17ec88e692fe12d8ee613043748a3e3792d782604ab5a8c4227b24fdbe3a7fc)
BibTeX
@misc{dcaf3fcbd71b7e,
  title = {Harnessing cellular immunotherapy for cholangiocarcinoma: an integrated roadmap for overcoming resistance — Europe PMC PMID:42183240},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42183240},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af3fcbd71b7e; sha256 e17ec88e692fe12d8ee613043748a3e3792d782604ab5a8c4227b24fdbe3a7fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42183240. Agents can read the archived copy with the MCP tool read_document.